FTC Second Request on MiMedx-Sanara Merger Extends HSR Waiting Period
SMTI has more than doubled off its 52-week low of $16.047.
Summary
The FTC issued a Second Request on the MiMedx-Sanara merger, extending the HSR waiting period until 30 days after both parties substantially comply. Shareholders already approved the deal, but closing is now delayed and the review carries more risk.
Key Events · M&A and Partnerships · SMTI
-
FTC Second Request Received
On October 15, 2026, Sanara and MiMedx each received a Second Request for additional information and documentary materials from the FTC regarding the pending merger.
-
HSR Waiting Period Extended
The Second Request extends the HSR Act waiting period until 30 days after the parties have substantially complied, unless extended voluntarily or terminated earlier by the FTC.
-
Closing Conditions Remain Open
Completion still requires expiration or termination of the HSR waiting period plus satisfaction or waiver of other closing conditions in the Merger Agreement.
-
Shareholder Approval Already Secured
Shareholders approved the MiMedx acquisition on September 30, 2026, leaving the FTC review as the remaining major gate.
Analysis · SMTI · Industrial Applications And Services
The FTC has demanded additional information and documentary materials from both Sanara and MiMedx, restarting the HSR clock: the waiting period now runs until 30 days after both parties substantially comply. Shareholders already approved the $33.00 cash plus 0.4735 MiMedx shares per share deal on September 30, so this is the last major regulatory gate — and a Second Request means the FTC found enough concern to dig deeper rather than clear the deal outright. Closing is now pushed out by at least the compliance period, and the deal remains exposed to further FTC action or a negotiated remedy. For a stock trading near its 52-week high at $35.00, essentially at the deal value, the risk is that a prolonged or blocked review compresses the spread or breaks the merger.
How filings like this one have moved
In the 30 days to Oct 31, 2026, 40% of the 987 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.59%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SMTI was trading at $35.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $322.4M. The 52-week trading range was $16.05 to $35.52. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.